SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Clinical evolution

Parexel tops analysts’ revenue, EPS expectations for Q2

03-Feb-2014 - Parexel narrowly beat investment analysts’ earnings per share and revenue expectations as consolidated service revenue hit $487.1m.

Cost and compliance turning CROs to outsourced site payment providers

23-Jan-2014 - The need to improve efficiency and comply with regulatory and geographical demands is driving the third-party clinical payment industry, say Greenphire, CFS and Clinverse.

Wuxi slightly raises financial expectations for 2013

20-Jan-2014 - WuXi PharmaTech has raised its 2013 financial guidance and now expects to achieve total revenues for 2013 of approximately $578m (€424m). 

breaking news

EU MEPs plan to make drugmakers make trial data public

20-Dec-2013 - Drugmakers and academics will have to upload the results of trials run in Europe to a public database under a provisional deal agreed in the European Parliament earlier today.

Siemens wins Pfizer companion diagnostics deal

17-Dec-2013 - German electronics firm Siemens has been contracted to develop and commercialize companion diagnostics by US drug giant Pfizer.

Algorithme teams with Montreal hospital to expand breadth of services

12-Dec-2013 - Algorithme Pharma has increased early stage patient access by teaming with a Montreal hospital, and says it provides a breadth of therapeutic areas not normally associated with mid-sized CROs.

update

Quotient Clinical bought by private equity investor

11-Dec-2013 - Early-stage development services firm Quotient Clinical has been bought by private equity organization, Bridgepoint Development Capital.

Dispatches from PCT

Parexel: Strategic partnerships are reshaping the CRO industry

02-Dec-2013 - Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry. 

Dispatches from PCT

Not all good news: CROs must prepare for Private Equity exit, experts say

02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT

Dispatches from PCT

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”

Dispatches from PCT

Pfizer: Active role for patients as smartphones lead way in virtual trials

25-Nov-2013 - Smartphones are changing the role of the patient in clinical trials and can be used for industry success, Pfizer and technology provider firm Exco InTouch said at PCT 2013.

PCT - Day 2

Ultravox wrong: Vienna 'everything' to CROs this week

19-Nov-2013 - CROs from across Europe and beyond have gathered in Vienna, Austria this week for Partnerships in Clinical Trials' (PCT) European congress. Outsourcing-pharma.com will be covering the show live.

News in brief

Synexus sets up Poland office

04-Nov-2013 - Patient recruitment firm Synexus has opened a new office in Wroclaw, Poland in the latest stage in in expansion in the country.

Quintiles ups EPS and narrows rev forecast

31-Oct-2013 - Quintiles issued a mixed set of revised financial predictions for 2013, increasing its earnings per share forecast after a surge of new business wins and narrowing its service revenue.

Covance reports strong Q3 with signs of early development recovery

30-Oct-2013 - Covance produced solid Q3 results as expected by analysts though whether the CRO can fire both early and late stage development cylinders at once remains a question. 

Parexel strikes another eClinical deal in Asia

15-Oct-2013 - Parexel has teamed up with Japanese trial management services firm Fuijitsu Systems West in an agreement that underlines the CROs eClinical growth ambitions in Asia.

Quintiles calls for voluntary, non-public release of masked clinical trial data

08-Oct-2013 - CRO Quintiles says it is in favor of the voluntary sharing of de-identified and masked clinical and preclinical data that protects the interests of research participants and proprietary data, though...

Almac launches online system to manage drug supply in trials

26-Sep-2013 - Almac has launched an online tool which it says will increase accuracy and save money in managing the supply of clinical trial supplies.

Update

InVentiv partnership will increase its access to trial site database

19-Sep-2013 - iCTRS (inVentiv Clinical Trial Recruitment Solutions) has partnered with ViS Research to accelerate the way it evaluates clinical trial sites.

Private Equity Group Buys eClinical Firm Bracket

22-Aug-2013 - Private equity group Parthenon Capital Partners has acquired eClinical services firm Bracket from US pharmacy benefit management organization Express Scripts.

EFPIA and PhRMA Accused of Mobilising Patients Against EU Trial Transparency Plans

23-Jul-2013 - The EFPIA and PhRMA are targeting an "army" of patient groups to lobby EU plans to publish clinical trial data, according to a leaked memo.

Wuxi Buys Instem’s Remote Study Monitoring Tool

23-Jul-2013 - China’s top CRO Wuxi Apptec has purchased a remote clinical trial monitoring tool that will allow its toxicology clients log onto a secure Web site to view data from on-going studies....

Update

AstraZeneca Partners with CRO-Like Institute to Develop Personalized Oncology Compounds

08-Jul-2013 - AstraZeneca has selected the Sarah Cannon Research Institute (SCRI) to help develop oncology compounds using molecular profiling to more accurately predict a patient's response.

Trial Site Feasibility Platform Looks to End Onerous Paper Questionnaires

03-Jul-2013 - The antiquated process of evaluating clinical trial sites through paper questionnaires may be coming to an end thanks to a new online platform.

Dispatches from DIA

CROs, Sponsors Yet to Cement Appropriate Risk-Sharing Models, Execs Say

01-Jul-2013 - Sponsors are piling on more responsibilities for their CRO partners, but the question of how that will translate into increases in risk and profit sharing is a point of contention.

Key Industry Events

 

Access all events listing

Our events, Events from partners...